Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report

Abrantes, 2020, A clinical approach to hypertrophic pachymeningitis, Arq Neuropsiquiatr, 78, 797, 10.1590/0004-282x20200073 Wallace, 2013, IgG4-Related Disease and hypertrophic pachymeningitis, Medicine (Baltimore), 92, 206, 10.1097/MD.0b013e31829cce35 Groot, 2001, Standardizaed neurologic evaluations of 128 patients with granulomatosis, Arch Neurol, 58, 1215, 10.1001/archneur.58.8.1215 Choi, 2017, Characteristics of pachymeningitis hypertrophic in patients with granulomatosis with polyangeitis, J Neurol, 264, 724, 10.1007/s00415-017-8416-0 Galnare-Olalde, 2018, Not everything is as is seems: neurosarcoidosis presenteing as leptomeningitis, Clin Case Rep, 6, 596, 10.1002/ccr3.1418 Fonseka, 2018, Tuberculous pachymeningitis presenting as a diffused dural thikening in patient with chronic headache and recurrent neurological abdnormalities for more than a decade: a case report and a review of litheratura, Case Rep Infect Dis, 2018 Bruce-Brand, 2020, Rosai-Dorfman disease: an overview, J Clin Pathol, 73, 697, 10.1136/jclinpath-2020-206733 Rodríguez, 2019, Emperipolesis en sindromes mielodiplasicos, Hematología, 23, 96 Sager, 2022, Adenopatias cervicales en reumatologia: un dilema diagnostico, Rev Colomb Reumatol, 205 Andriko, 2001, Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases, Mod Pathol, 14, 172, 10.1038/modpathol.3880278 Coffin, 1995, Extrapulmonary inflamatory myofibroblastic tumor (inflamatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases, Am J Surg Pathol, 19, 859, 10.1097/00000478-199508000-00001 Yamamoto, 2009, Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor. A comparative clinicopathologic study, Am J Surg Pathol, 33, 1330, 10.1097/PAS.0b013e3181a5a207 Perugino, 2017, IgG4-Related Disease: insights into human inmunology and targeted therapies, Arthritis Rheumatol, 69, 1722, 10.1002/art.40168 Stone, 2012, Recommendations for the nomenclature of IgG4-Related Disease and its individual organ system manifestations, Arthritis Rheum, 64, 3061, 10.1002/art.34593 Hattori, 2012, Isolated cutaneous manifestation of IgG4-Related Disease, J Clin Pathol, 65, 815, 10.1136/jclinpath-2012-200749 Okazaki, 2012, Are classification criteria for IgG4-RD now possible? The concept of IgG4-Related Disease and proposal of comprehensive diagnostic criteria in Japan, Int J Rheumatol, 2012, 10.1155/2012/357071 Zen, 2010, IgG4-Related Disease: a cross-sectional study of 114 cases, Am J Surg Pathol, 34, 1812, 10.1097/PAS.0b013e3181f7266b Lin, 2015, Clinical characteristics of inmunoglubulin G4-related disease: a prospective study of 118 Chinese patients, Rheumatology, 54, 1982, 10.1093/rheumatology/kev203 Wallace, 2020, The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease, Arthritis Rheumatol, 72, 7, 10.1002/art.41120 Stone, 2012, Mechanisms of disease IgG4-related disease, N Engl J Med, 366, 539, 10.1056/NEJMra1104650 Ardila-Suarez, 2017, Enfermedad relacionada con IgG4: revisión concisa de la literatura, Reumatol Clin, 13, 160, 10.1016/j.reuma.2016.05.009 Roverano, 2019, Paquimeningitis hipertrófica relacionada con IgC4: comunicación de otros 11 casos y revisión de la literatura, Rev Cub de Reu., 21, S1 Lu, 2014, IgG4-related hypertrophic pachymeningitis clinical features, diagnostic criteria, and treatment, JAMA Neurol, 71, 785, 10.1001/jamaneurol.2014.243 Desphande, 2012, Consensus statement on the pathology of IgG4-related disease, Modern Pathol, 25, 1181, 10.1038/modpathol.2012.72 Umehara, 2012, Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), Mod Rheumatol, 22, 21, 10.3109/s10165-011-0571-z Wallace, 2020, The 2019 American College of Rheumatology/European League against Rheumatism classification criteria of IgG4-Related Disease, Arthritis Rheumatol, 72, 7, 10.1002/art.41120 Lindstrom, 2010, IgG4-related meningeal disease: clinico-pathological featuresf and proposal for diagnostic criteria, Acta neuropathol, 120, 765, 10.1007/s00401-010-0746-2 Masaki, 2012, Cutoof values of serum IgG4 and Histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease, Int J Rheumatol, 2012, 10.1155/2012/580814 Della-Torre, 2014, Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis, J Neuroinmmunol, 266, 82, 10.1016/j.jneuroim.2013.10.008 Mahajan, 2014, IgG4-related disease, Annu Rev Pathol, 9, 315, 10.1146/annurev-pathol-012513-104708 Della-Torre, 2012, IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis, Ann Intern Med, 156, 401, 10.7326/0003-4819-156-5-201203060-00025 Della-Torre, 2013, Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis, J Rheumatol, 40, 1927, 10.3899/jrheum.130678 Fernandez-Codina, 2017, Alteration of IgG4 levels in cerebrospinal fluid in IgG4-related disease, Int J Rheum Dis, 20, 1865, 10.1111/1756-185X.12739 Khosroshahi, 2015, International consensus guidance statement on the management and treatment of IgG4-Related Disease, Arthritis Rheumatol, 67, 1688, 10.1002/art.39132 Norikane, 2012, Hypertrophic cranial pachymeningitis with IgG4-positive plasma cells detected by C-11 methionine PET, Clin Nucl Med, 37, 108, 10.1097/RLU.0b013e31823933c1